The Combination of TLR4 and TLR9 Agonists with Self-Amplifying RNA Lipid Nanoparticles Leads to a More Powerful Immune Response Against SARS-CoV-2
Viral Immunology · 2025
DOI: 10.1089/vim.2024.0099 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viral Immunology, 2025. Verfasst von Reza Keikha und 3 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases and Tropical Medicine Research Center, Resistant Tuberculosis Institute, Zahedan University of Medical Sciences, Zahedan, Iran. Hauptthemen laut MEDLINE: Nanoparticles, Toll-Like Receptor 4, SARS-CoV-2, Toll-Like Receptor 9. Die Arbeit nennt 33 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Infectious Diseases and Tropical Medicine Research Center, Resistant Tuberculosis Institute, Zahedan University of Medical Sciences, Zahedan, Iran.
- Department of Pathology, Faculty of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran.
- Department of Organic Chemistry, Faculty of Pharmaceutical Chemistry, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
- Department of Applied Chemistry, Faculty of Pharmaceutical Chemistry, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
- Department of Medical Nanotechnology, Faculty of Advanced Sciences and Technology, Tehran Medical Science, Islamic Azad University, Tehran, Iran.
ORCID-Profile: Ali Jebali
Zitieren
APA
Keikha, R., Balali, E., Khadivi, R., & Jebali, A. (2025). The Combination of TLR4 and TLR9 Agonists with Self-Amplifying RNA Lipid Nanoparticles Leads to a More Powerful Immune Response Against SARS-CoV-2. Viral Immunology. https://doi.org/10.1089/vim.2024.0099
Vancouver
Keikha R, Balali E, Khadivi R, Jebali A. The Combination of TLR4 and TLR9 Agonists with Self-Amplifying RNA Lipid Nanoparticles Leads to a More Powerful Immune Response Against SARS-CoV-2. Viral Immunology. 2025. doi:10.1089/vim.2024.0099
BibTeX
@article{Keikha2025,
author = {Keikha, Reza and Balali, Ebrahim and Khadivi, Ramona and Jebali, Ali},
title = {The Combination of TLR4 and TLR9 Agonists with Self-Amplifying RNA Lipid Nanoparticles Leads to a More Powerful Immune Response Against SARS-CoV-2},
journal = {Viral Immunology},
year = {2025},
doi = {10.1089/vim.2024.0099}
}
EUVIMED